ForFarmers N.V.

FFARM.AS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FFARM.AS stands at 353.4M. In comparison, RIN.PA has a market cap of 1.5B. Regarding current trading prices, FFARM.AS is priced at €4.00, while RIN.PA trades at €63.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FFARM.AS currently has a P/E ratio of 19.90, whereas RIN.PA's P/E ratio is 12.39. In terms of profitability, FFARM.AS's ROE is +0.10%, compared to RIN.PA's ROE of +0.07%. Regarding short-term risk, FFARM.AS is more volatile compared to RIN.PA. This indicates potentially higher risk in terms of short-term price fluctuations for FFARM.AS.

FFARM.AS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FFARM.AS stands at 353.4M. In comparison, SIP.BR has a market cap of 656.3M. Regarding current trading prices, FFARM.AS is priced at €4.00, while SIP.BR trades at €63.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FFARM.AS currently has a P/E ratio of 19.90, whereas SIP.BR's P/E ratio is 11.58. In terms of profitability, FFARM.AS's ROE is +0.10%, compared to SIP.BR's ROE of +0.08%. Regarding short-term risk, FFARM.AS is more volatile compared to SIP.BR. This indicates potentially higher risk in terms of short-term price fluctuations for FFARM.AS.

FFARM.AS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FFARM.AS stands at 353.4M. In comparison, OIZ.IR has a market cap of 397.9M. Regarding current trading prices, FFARM.AS is priced at €4.00, while OIZ.IR trades at €3.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FFARM.AS currently has a P/E ratio of 19.90, whereas OIZ.IR's P/E ratio is 7.61. In terms of profitability, FFARM.AS's ROE is +0.10%, compared to OIZ.IR's ROE of +0.11%. Regarding short-term risk, FFARM.AS is less volatile compared to OIZ.IR. This indicates potentially lower risk in terms of short-term price fluctuations for FFARM.AS.

FFARM.AS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FFARM.AS stands at 353.4M. In comparison, MLGDI.PA has a market cap of 65.6M. Regarding current trading prices, FFARM.AS is priced at €4.00, while MLGDI.PA trades at €0.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FFARM.AS currently has a P/E ratio of 19.90, whereas MLGDI.PA's P/E ratio is N/A. In terms of profitability, FFARM.AS's ROE is +0.10%, compared to MLGDI.PA's ROE of N/A. Regarding short-term risk, FFARM.AS is more volatile compared to MLGDI.PA. This indicates potentially higher risk in terms of short-term price fluctuations for FFARM.AS.

FFARM.AS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FFARM.AS stands at 353.4M. In comparison, MLAAH.PA has a market cap of 23.9M. Regarding current trading prices, FFARM.AS is priced at €4.00, while MLAAH.PA trades at €0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FFARM.AS currently has a P/E ratio of 19.90, whereas MLAAH.PA's P/E ratio is -1.50. In terms of profitability, FFARM.AS's ROE is +0.10%, compared to MLAAH.PA's ROE of -0.34%. Regarding short-term risk, FFARM.AS is more volatile compared to MLAAH.PA. This indicates potentially higher risk in terms of short-term price fluctuations for FFARM.AS.

FFARM.AS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FFARM.AS stands at 353.4M. In comparison, DQ7A.IR has a market cap of 23.1M. Regarding current trading prices, FFARM.AS is priced at €4.00, while DQ7A.IR trades at €18.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FFARM.AS currently has a P/E ratio of 19.90, whereas DQ7A.IR's P/E ratio is 10.11. In terms of profitability, FFARM.AS's ROE is +0.10%, compared to DQ7A.IR's ROE of +0.09%. Regarding short-term risk, FFARM.AS is more volatile compared to DQ7A.IR. This indicates potentially higher risk in terms of short-term price fluctuations for FFARM.AS.

FFARM.AS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FFARM.AS stands at 353.4M. In comparison, ALKKO.PA has a market cap of 23M. Regarding current trading prices, FFARM.AS is priced at €4.00, while ALKKO.PA trades at €0.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FFARM.AS currently has a P/E ratio of 19.90, whereas ALKKO.PA's P/E ratio is 14.10. In terms of profitability, FFARM.AS's ROE is +0.10%, compared to ALKKO.PA's ROE of -0.08%. Regarding short-term risk, FFARM.AS is less volatile compared to ALKKO.PA. This indicates potentially lower risk in terms of short-term price fluctuations for FFARM.AS.

FFARM.AS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FFARM.AS stands at 353.4M. In comparison, ALAGR.PA has a market cap of 11.5M. Regarding current trading prices, FFARM.AS is priced at €4.00, while ALAGR.PA trades at €0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FFARM.AS currently has a P/E ratio of 19.90, whereas ALAGR.PA's P/E ratio is -2.60. In terms of profitability, FFARM.AS's ROE is +0.10%, compared to ALAGR.PA's ROE of -0.29%. Regarding short-term risk, FFARM.AS is less volatile compared to ALAGR.PA. This indicates potentially lower risk in terms of short-term price fluctuations for FFARM.AS.

FFARM.AS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FFARM.AS stands at 353.4M. In comparison, CPA.LS has a market cap of 0. Regarding current trading prices, FFARM.AS is priced at €4.00, while CPA.LS trades at €13.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FFARM.AS currently has a P/E ratio of 19.90, whereas CPA.LS's P/E ratio is 9.32. In terms of profitability, FFARM.AS's ROE is +0.10%, compared to CPA.LS's ROE of +0.13%. Regarding short-term risk, FFARM.AS is more volatile compared to CPA.LS. This indicates potentially higher risk in terms of short-term price fluctuations for FFARM.AS.